ALGS

ALIGOS THERAPEUTICS INC

ALGS·01626L204·US·Common Stock·Healthcare - Biotechnology-Activist

ALGS (ALIGOS THERAPEUTICS INC) is held by 25 institutional investors as of Q2 2026. Largest holders: Alyeska Investment Group, L.P. ($2.4M), MARSHALL WACE, LLP ($1.4M), Woodline Partners LP ($1M). Net institutional sentiment: Mixed.

25
Holders
$8.8M
Total Value
42% (24)
Consensus
10 buying - 14 selling
13F: Insider & Congress: Updated regularly
ALGS

Smart Money Verdict

View all
Loading verdict
Held by 25 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Jun 24, 2026 · Congress none

ActivistLMLawrence M. Blatt5.6%Jun 24, 2026
ActivistLMLawrence M. Blatt5.1%May 15, 2026
ActivistWoodline Partners LPWoodline Partners LP4.4%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
412,000$2.4M0.0%-17.65%
0
Decreased
246,579(-7.7%)$1.4M0.0%-17.65%
0
Unchanged
177,362$1M0.0%-10.30%
0
Decreased
175,543(-1.5%)$1M0.0%+9.64%
0
Unchanged
83,055$479,2270.0%-98.72%
0
Unchanged
76,247$439,9450.1%-98.06%
0
Increased
66,463(+505.4%)$383,4910.0%+26.25%
38
Increased
59,986(+61.9%)$346,1190.0%+15.79%
23
Decreased
47,173(-5.6%)$272,3190.0%-94.01%
0
New
32,402$186,9590.0%+30.16%
35
Increased
30,292(+132.3%)$174,7850.0%-63.73%
25
Increased
28,612(+0.6%)$165,0910.0%+9.74%
15
New
21,044$121,4240.0%+30.16%
34
Unchanged
18,887$108,9780.0%-17.65%
0
New
12,339$71,1960.0%+30.16%
29
Decreased
10,800(-89.3%)$62,3160.0%-35.79%
0
Unchanged
10,000$57,7000.0%-18.10%
0
Increased
4,650(+389.5%)$26,8310.0%+25.36%
31
Unchanged
2,125$12,0000.0%-68.50%
0
New
1,808$10,4320.0%+30.16%
26

Showing 1-20 of 32

1 / 2
ALGSALGSALIGOS THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used